Allarity Therapeutics Has Received A Decision To Grant European Patent Number EP3794149 Titled "METHODS FOR PREDICTING DRUG RESPONSIVENESS IN CANCER PATIENTS".
Allarity Therapeutics Has Received A Decision To Grant European Patent Number EP3794149 Titled "METHODS FOR PREDICTING DRUG RESPONSIVENESS IN CANCER PATIENTS".
Allarity Therapeutics已獲得歐洲專利號EP3794149,題爲"預測癌症患者藥物響應性的方法"。
Allarity Therapeutics Has Received A Decision To Grant European Patent Number EP3794149 Titled "METHODS FOR PREDICTING DRUG RESPONSIVENESS IN CANCER PATIENTS".
Allarity Therapeutics已收到授予的歐洲專利號EP3794149,標題爲"癌症患者藥物反應預測方法"。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。